Pharmabiz15m
Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma
Johnson & Johnson announced the submission of regulatory applications to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking approval of a new indication for Darzalex ...
Pharmabiz15m
US FDA clears SystImmune’s IND application for BL-M17D1 in advanced solid tumours
SystImmune, Inc (SystImmune), a clinical-stage biotechnology company, announced that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for BL-M17D1, ...
Pharmabiz15m
Quantiphi and DDReg partner to transform regulatory reporting in life sciences through AI
Quantiphi and DDReg partner to transform regulatory reporting in life sciences through AI: Our Bureau, Bengaluru Monday, November 11, 2024, 13:45 Hrs [IST] Quantiphi, a global AI- ...
Pharmabiz15m
EMA’s veterinary committee issues first certificate for vaccine platform technology master file
EMA's Committee for Veterinary Medicinal Products (CVMP) has issued the first certificate for a vaccine platform technology master file (vPTMF) which will support and accelerate the development and ...
Pharmabiz6h
Ayush and herbal products exports grow over 10 per cent in H1 FY25
Exports of Ayush and herbal products for the first six months of the current fiscal has reported a 10.34 per cent growth, as ...
Pharmabiz2h
RPG Life Sciences appoints Ashok Nair as managing director (designate) following superannuation of Yugal Sikri
RPG Life Sciences appoints Ashok Nair as managing director (designate) following superannuation of Yugal Sikri: Our Bureau, Bengaluru Monday, November 11, 2024, 12:15 Hrs [IST] RP ...
Pharmabiz2h
Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older
Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...
Pharmabiz2h
Health Vectors unveils Smart Health Report to spur future of personal health analytics
Health Vectors unveils Smart Health Report to spur future of personal health analytics: Our Bureau, Bengaluru Monday, November 11, 2024, 12:30 Hrs [IST] Health Vectors (HV), a hea ...
Pharmabiz1h
Nammi Therapeutics begins patient dosing in phase 1 study of QXL138AM for advanced solid tumours and multiple myeloma
Nammi Therapeutics begins patient dosing in phase 1 study of QXL138AM for advanced solid tumours and multiple myeloma: Los Angeles Monday, November 11, 2024, 13:00 Hrs [IST] Nammi ...
Pharmabiz3h
Akums Drugs and Pharmaceuticals net profit doubles in Q2FY25
Akums Drugs and Pharmaceuticals has witnessed its net profit for the second quarter of the current fiscal year doubling to Rs. 66.65 crore from Rs. 32.69 crore registered during the same quarter last ...
Pharmabiz3h
Divis Laboratories net profit grew 47% in Q2FY25
Our Bureau, New Delhi Monday, November 11, 2024, 11:15 Hrs [IST] Hyderabad-based Divis Laboratories has registered a growth of 46 ...
Pharmabiz3h
Aurobindo Pharma net profit grows 8.6% in Q2FY25
Our Bureau, New Delhi Monday, November 11, 2024, 10:45 Hrs [IST] Hyderabad-based Aurobindo Pharma has registered a growth of 8.6 ...